Modelling the dynamics of Anti-HBV Infection Therapy with Chinese Herbs

被引:0
|
作者
Ye, Yongan [1 ]
Min, Lequan [2 ]
机构
[1] Beijing Univ Chinese Med, Dongzhimen Hosp, Beijing 100700, Peoples R China
[2] Univ Sci & Technol Beijing, Appl Sci Sch, Beijing 100083, Peoples R China
关键词
hepatitis B; Chinese Herbs; anti-HBV infection therapy model; CHRONIC HEPATITIS-B; VIRUS-INFECTION; COMBINATION; LAMIVUDINE;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Effective treatment of chronic Hepatitis B virus (HBV) patients aims to prevent progression of chronic hepatitis B to cirrhosis, hepatocellular carcinoma, and eventually death. The use of mathematical modelling to explain the anti-HBV infection therapy has made a significant contribution for understanding the dynamics of host cells, viruses, the immune system. Chinese herbs are playing important roles for anti-HBV infection treatment. Recently a new type of Chinese herbs (NTCH) has been proved to be effective for anti-HBV infection therapy. Based on a patient's anti-hepatitis B virus (HBV) infection therapy clinical data with the NTCH and our previous modified basic virus infection model [1], a new differential equation model with an immune variable is set up. The numerical simulations of the model show that the evolution of the HBV DNA of the model is agreement with in the patient's clinic plasma HBV DNA levels. The model predicts that it needs to prolong the treatment time to 4.3 years to eliminate NTCH the HBV virus in the patient's infected hepatocytes. Otherwise earlier cessation of the therapy will make the patient's HBV DNA levels return rapidly.
引用
收藏
页码:83 / +
页数:2
相关论文
共 50 条
  • [21] Future anti-HBV strategies
    Gane, Edward J.
    LIVER INTERNATIONAL, 2017, 37 : 40 - 44
  • [22] Clevudine - Levovir - Anti-HBV
    不详
    DRUGS OF THE FUTURE, 2001, 26 (08) : 797 - 798
  • [23] MicroRNA profiling of circulating exosomes in HBV cirrhosis patients following anti-HBV therapy
    Cong, Min
    Chen, Li
    Liu, Tianhui
    Wang, Ping
    Jia, Jidong
    Brigstock, David
    You, Hong
    HEPATOLOGY, 2015, 62 : 896A - 896A
  • [24] Anti-HBV effectiveness and mechanisms of Chinese herbal extract-Suduxing
    Yao, Weiming
    Liu, Yan
    Xu, Zhihui
    Si, Lanlan
    Li, Penggao
    Bo, Lvping
    Lan, Jinchu
    Xu, Dongping
    HEPATOLOGY, 2014, 60 : 1111A - 1111A
  • [25] The role of Traditional Chinese medicine in anti-HBV: background, progress, and challenges
    Ge, Feilin
    Yang, Yan
    Bai, Zhaofang
    Si, Lanlan
    Wang, Xuemei
    Yu, Jia
    Xiao, Xiaohe
    Liu, Yan
    Ren, Zhigang
    CHINESE MEDICINE, 2023, 18 (01)
  • [26] The role of Traditional Chinese medicine in anti-HBV: background, progress, and challenges
    Feilin Ge
    Yan Yang
    Zhaofang Bai
    Lanlan Si
    Xuemei Wang
    Jia Yu
    Xiaohe Xiao
    Yan Liu
    Zhigang Ren
    Chinese Medicine, 18
  • [27] Comprehensive investigation of HBV-related hepatocellular carcinoma and choice of anti-HBV therapy
    Lu, Huihui
    Yi, Wei
    Sun, Fangfang
    Zeng, Zhan
    Zhang, Lu
    Li, Minghui
    Xie, Yao
    BIOSAFETY AND HEALTH, 2021, 3 (04) : 190 - 196
  • [28] Infectivity plays a major role in the selection of HBV variants during anti-HBV therapy
    Villet, S.
    Billioud, G.
    Pichoud, C.
    Lucifora, J.
    Hantz, O.
    Sureau, C.
    Deny, P.
    Zoulim, E.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S253 - S253
  • [29] HBV X-gene:A new serum marker for anti-HBV therapy monitoring
    张伟
    李艳红
    朱少君
    巩丽
    王姝妹
    冯英明
    Journal of Medical Colleges of PLA, 2007, (06) : 370 - 372
  • [30] A time delay anti-HBV infection treatment mathematical model with adefovir
    Wu, Y. T.
    Su, Y. M.
    Min, L. Q.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S72 - S72